BRIEF published on 05/31/2024 at 17:03, 1 year 11 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA FDA Approval Moderna Vaccine RSV MRESVIA
BRIEF published on 05/31/2024 at 17:03, 1 year 11 months ago Moderna reçoit l'approbation de la FDA américaine pour le vaccin contre le RSV mRESVIA Approbation De La FDA Moderne VRS MRESVIA Vaccin
PRESS RELEASE published on 05/31/2024 at 16:58, 1 year 11 months ago Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) Moderna gains FDA approval for mRESVIA, a single-dose pre-filled syringe RSV vaccine for adults 60+ to prevent lower respiratory tract disease. Second mRNA product and breakthrough therapy designation FDA Approval Moderna RSV Vaccine MRNA MRESVIA
BRIEF published on 05/22/2024 at 13:05, 1 year 11 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Clinical Trials Immunotherapy Moderna ASCO 2024 MRNA-4157
BRIEF published on 05/22/2024 at 13:05, 1 year 11 months ago Moderna annonce que les données seront présentées lors de l'assemblée annuelle 2024 de l'ASCO Immunothérapie Essais Cliniques Moderne ASCO 2024 ARNm-4157
PRESS RELEASE published on 05/22/2024 at 13:00, 1 year 11 months ago Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting Moderna to host an investor event via webcast on June 3 at 6:15 PM CDT. Abstracts on mRNA-4157 for ASCO Annual Meeting. Details on mRNA-4157 (V940) therapy development Webcast Moderna Investor Event MRNA-4157 Neoantigen Therapy
BRIEF published on 05/13/2024 at 13:05, 1 year 11 months ago Moderna Announces Participation in Key Investor Conferences Investor Conferences Healthcare Financial Markets Moderna Webcasts
BRIEF published on 05/13/2024 at 13:05, 1 year 11 months ago Moderna annonce sa participation à des conférences clés pour les investisseurs Marchés Financiers Soins De Santé Conférences Investisseurs Moderne Webdiffusions
PRESS RELEASE published on 05/13/2024 at 13:00, 1 year 11 months ago Moderna to Present at Upcoming Conferences in May/June 2024 Moderna, Inc. to participate in upcoming investor conferences, showcasing its leadership in mRNA medicine and innovative approach to disease treatment. Live webcasts available Investor Conferences Moderna Inc. MRNA Medicine Webcasts Disease Treatment
BRIEF published on 05/02/2024 at 12:35, 2 years ago Moderna Reports Q1 2024 Financial Performance and Strategic Progress Financial Results MRNA Technology Moderna RSV Vaccine Vaccine Development
Published on 05/04/2026 at 14:08, 4 minutes ago Critical Elements' 10,000-Metre Drill Program at Rose West Continues to Deliver Positive Results
Published on 05/04/2026 at 14:08, 4 minutes ago critical elements - le programme de forage de 10 000 mètres à rose ouest continu de livrer des résultats positifs
Published on 05/04/2026 at 14:00, 12 minutes ago CHAR Tech Appoints Infrastructure & Capital Markets Veteran Kevin Melnyk as CFO and Reminds Shareholders of Upcoming AGM
Published on 05/04/2026 at 13:54, 18 minutes ago EQS-Adhoc: Borussia Dortmund publishes preliminary figures for the third quarter (Q3) of the 2025/2026 financial year
Published on 05/04/2026 at 13:35, 37 minutes ago DeFi Technologies Announces Shareholder Call to Discuss Q1 2026 Financial Results
Published on 05/04/2026 at 13:20, 51 minutes ago North Peak Resources Announces Agreement to Repurchase 1 Million Common Shares for Cancellation
Published on 05/04/2026 at 13:08, 1 hour 4 minutes ago MEDICLIN increases group operating result in the first quarter
Published on 05/04/2026 at 12:40, 1 hour 32 minutes ago EQS-Adhoc: SOWITEC group GmbH and the Joint Representative enter into a deferral agreement regarding a partial repayment of the bond 2018/2026
Published on 05/04/2026 at 09:51, 4 hours 21 minutes ago GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres du 27 avril 2026 au 1er mai 2026
Published on 05/04/2026 at 09:51, 4 hours 21 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From April 27th 2026 to May 1st 2026
Published on 05/04/2026 at 08:45, 5 hours 27 minutes ago Air Liquide divests its biogas production activities in four countries
Published on 05/04/2026 at 08:45, 5 hours 27 minutes ago Air Liquide cède ses activités de production de biogaz dans quatre pays
Published on 05/04/2026 at 08:30, 5 hours 42 minutes ago ENGIE concrétise ses deux premiers projets éoliens en mer en France
